DGAP-News

DAVID BERNSTEIN, M.D. JOINS PAION AS MEDICAL ADVISOR & NON EXECUTIVE DIRECTOR OF PAION INC

DGAP-News: PAION AG / Key word(s): Change of Personnel
DAVID BERNSTEIN, M.D. JOINS PAION AS MEDICAL ADVISOR & NON EXECUTIVE
DIRECTOR OF PAION INC

07.05.2015 / 14:00

---------------------------------------------------------------------

DAVID BERNSTEIN, M.D. JOINS PAION AS MEDICAL ADVISOR & NON EXECUTIVE
DIRECTOR OF PAION INC

- Dr. Bernstein will support PAION in its effort to bring Remimazolam to
the U.S. market

- Dr. Bernstein will also provide PAION with strategic insight and work
closely with PAION's advisory board of U.S. thought leaders

- PAION to be present at the DDW congress (May 17-19, 2015) in
Washington, U.S. at booth 1865

Aachen, 07 May 2015 - PAION AG, a Specialty Pharmaceutical Company (ISIN
DE000A0B65S3; Frankfurt Stock Exchange Prime Standard: PA8) is pleased to
announce today that David Bernstein, M.D. has agreed to become PAION's
Medical Advisor. In this role, Dr. Bernstein will participate in building
the company's U.S. relationships with the academic community, regulators,
associations and industry. He will also play an active role in the growth
of the company's value proposition, with a special focus on the U.S.

Dr. Bernstein will also be heavily involved in steering PAION's efforts
with its recently established medical advisory board, which consists of
U.S. national thought leaders in the field of gastroenterology who are also
participating in our phase III program.

Dr Wolfgang Söhngen, M.D., Ph.D., chief executive officer of PAION AG,
said, "I'm thrilled to continue to work with Dr. Bernstein to bring
Remimazolam to a commercial success. David's contributions in helping us
put together our medical advisory board last year were significant. We hope
this will be a long and rewarding relationship with one of the most
respected physicians in the field of gastroenterology."

Greg Papaz, president and chief executive officer of PAION, Inc., added:
"It is a privilege to have a physician of David's prestige as a director of
PAION Inc. I am confident he will help us achieve our goals in the U.S."

Dr. Bernstein is currently chief of hepatology for both North Shore
University Hospital and Long Island Jewish Hospital, as well as the
director of the Center for Liver Diseases for the North Shore LIJ Health
System and a professor of medicine at the Hofstra North Shore LIJ School of